Advertisement
Person › Details
Charles (Charlie) McDermott (Primmune Therapeutics Inc.)
McDermott, Charles (Charlie) (Primmune Therapeutics 202103 CEO formerly Kala Pharmaceuticals Inc. 201504 CBO)
Organisation | Primmune Therapeutics Inc. | |
Former/major organisation | Kala Pharmaceuticals Inc. | |
Product | TLR7 agonist | |
Product 2 | drug development | |
Record changed: 2021-12-10 |
Advertisement
More documents for Charles (Charlie) McDermott
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top